thumbprint
ASCRS Government relations

Advocacy

As a key pillar of our mission, ASCRS and our members advocate on behalf of our profession to Congress and the administration, including regulatory agencies, such as HHS, CMS, and FDA. ASCRS is committed to ensuring a legislative and regulatory landscape that allows members to continue providing high-quality care to patients.

Resources for Telemedicine During COVID-19 Public Health Emergency

During the COVID-19 public health emergency, telemedicine may be an option for treating some patients. CMS has lifted existing regulations that limit the ability to bill Medicare beneficiaries for telemedicine visits. Visit our telemedicine page for full details on the emergency expansion of telemedicine and access our guide to tele-ophthalmology and our recent webinar on telemedicine during the COVID-19 pandemic.  Telemedicine Resources

ASCRS Government Relations: What we Do

ASCRS advocates on behalf of our members on Capitol Hill and to regulatory agencies. We are committed to preserving access to high-quality specialty care. ASCRS members are engaged in the political process through eyePAC, our nonpartisan political action committee, and the eyeContact grassroots program. 


Get involved

Dispelling the Myths about the Cataract Episode-Based Cost Measure: What's Included and What's Not

This webinar will assist ASCRS and ASOA members understand the 2020 Cataract Episode-Based Cost Measure that is included in the 2020 MIPS Cost Category. 


Download the slides

ASCRS MACRA Center

ASCRS and ASOA members have complete access to in-depth, ophthalmology-specific information on MACRA. The MACRA Center covers the Quality Payment Program (QPP) that includes MIPS and APMs.


MACRA CENTER

2020 Medicare Physician Fee Schedule Final Rule

Additional information on understanding the impact of CMS' 2020 payment policies.

Read more

ASCRS Priority Issues

 

Increasing the Value of E/M Visits Included in Global Codes and Eliminating the Add-On Code

Increasing the value of post-operative E/M visits included in 10- and 90-day global surgery codes; and the elimination or non-budget neutral implementation of the E/M add on code.

Read more

Medicare Physician Payment: Positive Updates

Congress must extend positive physician payment updates to the conversion factor to ensure that Medicare fee-for-service (FFS) and the programs under MACRA continue to be viable options for ophthalmologists.

Read more

MACRA Regulatory Reforms

ASCRS strongly opposes certain provisions of the 2020 final rule pertaining to the QPP, including potentially making its new  participation pathway for 2021, the MIPS Value Pathways (MVPs) mandatory, inclusion of FDA-approved pass-through drugs in the cataract surgery episode-based cost measure, and removing “topped-out” ophthalmology measures.  

Read more

Regulatory Relief

Advocating for regulatory changes that will alleviate the administrative burden on practices, so that physicians can focus on providing high-quality care to patients. 

Read more

Support Advocacy through EyePAC

eyePac is a voluntary, non-partisan political action committee representing ophthalmic surgeons. Your investment in eyePAC helps ASCRS support candidates for the U.S. Senate and House of Representatives who fight for the issues important to you and your practice. 


Learn More

ASCRS and the Alliance of Specialty Medicine

ASCRS is a member of the the Alliance of Specialty Medicine, a coalition of 14 “like-minded” specialty medical groups focused on preserving access to specialty care.

 
Read More

Contact ASCRS Government Relations

Main: 703-591-2220

Nancey McCann

Director of Government Relations

nmccann@ascrs.org

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.